DERMOSCRIBE ICHYBUM- hydrocortisone, clioquinol, zinc oxide cream

DERMOSCRIBE ICHYBUM by

Drug Labeling and Warnings

DERMOSCRIBE ICHYBUM by is a Otc medication manufactured, distributed, or labeled by DERMOSCRIBE PTY LTD. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

CONTAINS: HYDROCORTISONE 1%, CLIOQUINOL 1%, ZINC OXIDE CREAM

PURPOSE

PURPOSE

ANAL ITCHING

INDICATIONS & USAGE

DERMOSCRIBE'S ICHYBUM ANAL ITCHING CREAM IS A TOPICAL TREATMENT FOR RELIEF OF THE SYMPTOMS OF PRURITUS ANI AND OTHER AFFLICTIONS INVOLVING CHRONIC ITCHING AROUND THE ANUS.

WARNINGS

WARNINGS

FOR EXTERNAL USE ONLY

USE ONLY IN ACCORDANCE WITH DIRECTIONS ON LABEL AND WITHIN THE PACKAGING. SEEK MEDICAL ADVICE IF PREGNANT OR BREASTFEEDING. AVOID EYES. DO NOT SWALLOW. CONSULT A HEALTHCARE PROFESSIONAL ABOUT LONG TERM USE. IF IRRITATION DEVELOPS, SEEK MEDICAL ADVICE. MAY NOT BE AS EFFECTIVE BEYOND EXPIRY DATE. REFER TO ENCLOSED LEAFLET FOR DETAILED DIRECTIONS.

KEEP OUT OF REACH OF CHILDREN

KEEP OUT OF REACH OF CHILDREN.

DOSAGE & ADMINISTRATION

DIRECTIONS
FOR USE ONLY BY ADULTS AND CHILDREN OVER 12 YEARS.
APPLY A SMALL AMOUNT IN A THIN LAYER OVER THE AFFECTED AREA ONCE OR TWICE DAILY AS REQUIRED, PREFERABLY AFTER SHOWERING AND/OR BOWEL MOVEMENTS AS WELL AS AT NIGHT BEFORE SLEEP.

INACTIVE INGREDIENT

INACTIVE INGREDIENTS

ZINC OXIDE, WATER

OTHER SAFETY INFORMATION

STORE AT ROOM TEMPERATURE

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

DERMOSCRIBE ICHYBUM 
hydrocortisone, clioquinol, zinc oxide cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 69683-101
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
HYDROCORTISONE (UNII: WI4X0X7BPJ) (HYDROCORTISONE - UNII:WI4X0X7BPJ)	HYDROCORTISONE	1 g  in 100 g
CLIOQUINOL (UNII: 7BHQ856EJ5) (CLIOQUINOL - UNII:7BHQ856EJ5)	CLIOQUINOL	1 g  in 100 g

Inactive Ingredients
Ingredient Name	Strength
ZINC OXIDE (UNII: SOI2LOH54Z)
WATER (UNII: 059QF0KO0R)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 69683-101-11	28 g in 1 BOTTLE; Type 0: Not a Combination Product	03/23/2015

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph not final	part348	03/23/2015

Labeler - XLMA PTY LTD (742164734)